EUVIMEDEUVIMED entdecken
Open Access

Progress and New Challenges in Combatting the Threat of Antimicrobial Resistance: Perspective From an Infectious Diseases Pharmacist

Ryan K Shields

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Ryan K Shields. Beteiligte Einrichtung: Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Pharmacists, Communicable Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ryan K Shields; Progress and new challenges in combatting the threat of antimicrobial resistance: Perspective from an Infectious Diseases pharmacist, The Journa

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacistsCommunicable DiseasesHumansAnti-Bacterial AgentsDrug Resistance, Bacterial

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Förderung

  • NIAID NIH HHS
  • NIH

Zitieren

APA

Shields, R. K. (2024). Progress and New Challenges in Combatting the Threat of Antimicrobial Resistance: Perspective From an Infectious Diseases Pharmacist. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad250

Vancouver

Shields RK. Progress and New Challenges in Combatting the Threat of Antimicrobial Resistance: Perspective From an Infectious Diseases Pharmacist. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad250

BibTeX
@article{Shields2024,
  author = {Shields, Ryan K},
  title = {Progress and New Challenges in Combatting the Threat of Antimicrobial Resistance: Perspective From an Infectious Diseases Pharmacist},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad250}
}
Kostenlos starten →